JP2024525610A5 - - Google Patents
Info
- Publication number
- JP2024525610A5 JP2024525610A5 JP2024500477A JP2024500477A JP2024525610A5 JP 2024525610 A5 JP2024525610 A5 JP 2024525610A5 JP 2024500477 A JP2024500477 A JP 2024500477A JP 2024500477 A JP2024500477 A JP 2024500477A JP 2024525610 A5 JP2024525610 A5 JP 2024525610A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163219977P | 2021-07-09 | 2021-07-09 | |
| US63/219,977 | 2021-07-09 | ||
| PCT/US2022/073528 WO2023283614A2 (en) | 2021-07-09 | 2022-07-08 | Muscle targeting complexes and uses thereof for treating dystrophinopathies |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024525610A JP2024525610A (ja) | 2024-07-12 |
| JP2024525610A5 true JP2024525610A5 (https=) | 2025-07-17 |
| JPWO2023283614A5 JPWO2023283614A5 (https=) | 2025-07-17 |
Family
ID=84802085
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024500477A Pending JP2024525610A (ja) | 2021-07-09 | 2022-07-08 | 筋標的化複合体およびジストロフィノパチーを処置するためのその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240209119A1 (https=) |
| EP (1) | EP4367247A4 (https=) |
| JP (1) | JP2024525610A (https=) |
| KR (1) | KR20240035823A (https=) |
| CN (1) | CN118510898A (https=) |
| AU (1) | AU2022307934A1 (https=) |
| CA (1) | CA3226298A1 (https=) |
| IL (1) | IL309909A (https=) |
| MX (1) | MX2024000490A (https=) |
| WO (1) | WO2023283614A2 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220193250A1 (en) | 2018-08-02 | 2022-06-23 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy |
| US12370264B1 (en) | 2018-08-02 | 2025-07-29 | Dyne Therapeutics, Inc. | Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of delivering oligonucleotide to a subject |
| EP3829595A4 (en) | 2018-08-02 | 2022-08-24 | Dyne Therapeutics, Inc. | MUSCLE-DIRECTED COMPLEXES AND USES THEREOF IN THE TREATMENT OF DYSTROPHINOPATHIES |
| US12097263B2 (en) | 2018-08-02 | 2024-09-24 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
| US12018087B2 (en) | 2018-08-02 | 2024-06-25 | Dyne Therapeutics, Inc. | Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of delivering oligonucleotide to a subject |
| US11168141B2 (en) | 2018-08-02 | 2021-11-09 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating dystrophinopathies |
| US11911484B2 (en) | 2018-08-02 | 2024-02-27 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
| IL309936A (en) | 2021-07-09 | 2024-03-01 | Dyne Therapeutics Inc | Muscle targeting complexes and formulations for the treatment of dystrophinopathy |
| US11771776B2 (en) | 2021-07-09 | 2023-10-03 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating dystrophinopathies |
| US11638761B2 (en) | 2021-07-09 | 2023-05-02 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating Facioscapulohumeral muscular dystrophy |
| US11969475B2 (en) | 2021-07-09 | 2024-04-30 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy |
| US11672872B2 (en) | 2021-07-09 | 2023-06-13 | Dyne Therapeutics, Inc. | Anti-transferrin receptor antibody and uses thereof |
| US11633498B2 (en) | 2021-07-09 | 2023-04-25 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
| US20250339553A1 (en) | 2022-04-15 | 2025-11-06 | Dyne Therapeutics, Inc. | Muscle targeting complexes and formulations for treating myotonic dystrophy |
| AU2024299328A1 (en) | 2023-07-21 | 2026-01-22 | Marrow Therapeutics, Inc. | Hematopoietic cell targeting conjugates and related methods |
| CN118546927B (zh) * | 2024-05-29 | 2025-02-25 | 广东省农业科学院动物科学研究所 | 一种靶向敲低鸡SRSF2基因表达的siRNA及其应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2008317566B2 (en) * | 2007-10-26 | 2014-05-01 | Academisch Ziekenhuis Leiden | Means and methods for counteracting muscle disorders |
| EP3829595A4 (en) * | 2018-08-02 | 2022-08-24 | Dyne Therapeutics, Inc. | MUSCLE-DIRECTED COMPLEXES AND USES THEREOF IN THE TREATMENT OF DYSTROPHINOPATHIES |
| KR20230044242A (ko) * | 2020-07-23 | 2023-04-03 | 다인 세라퓨틱스, 인크. | 근육 표적화 복합체 및 디스트로핀병증을 치료하기 위한 그의 용도 |
-
2022
- 2022-07-08 MX MX2024000490A patent/MX2024000490A/es unknown
- 2022-07-08 JP JP2024500477A patent/JP2024525610A/ja active Pending
- 2022-07-08 CN CN202280060816.6A patent/CN118510898A/zh active Pending
- 2022-07-08 WO PCT/US2022/073528 patent/WO2023283614A2/en not_active Ceased
- 2022-07-08 AU AU2022307934A patent/AU2022307934A1/en active Pending
- 2022-07-08 EP EP22838586.0A patent/EP4367247A4/en active Pending
- 2022-07-08 KR KR1020247004286A patent/KR20240035823A/ko active Pending
- 2022-07-08 CA CA3226298A patent/CA3226298A1/en active Pending
- 2022-07-08 US US18/577,462 patent/US20240209119A1/en active Pending
- 2022-07-08 IL IL309909A patent/IL309909A/en unknown